Retour aux projets

12667.1;4 PFLS-LS

HIT to LEAD to Candidate development of a Transcription Repressor Inhibitory Compound (TRIC), which switches off bacterial resistance to a broad band antibiotic

Résumé

HIT to LEAD to Candidate development of a Transcription Repressor Inhibitory Compound (TRIC), which switches off bacterial resistance to a broad band antibiotic

Textes supplémentaires

Abstract

A new and highly innovative treatment will be realized by a novel and patentable orally available small molecule combinatorial drug candidate for the treatment of antibiotic resistance in multi-resistant, pathogenic bacterial strains. The consortium integrates medicinal chemistry (Dr. Riedl, ZHAW), biological assays and screening (BioVersys AG) with high-end characterization of binding interactions (Prof. Dr. Gygax, FHNW). HIT compounds identified during two SATW projects will be developed into a clinical candidate utilizing all the experiences in the consortium.

Participants

Rainer Riedl

Kontaktperson

rainer.riedl@zhaw.ch

ZHAW Rainer Riedl Einsiedlerstrasse 31 8820 Wädenswil ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2011-10-31
Date de fin
2014-03-11
Coûts totaux approuvés
CHF 557507.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • P004 Biochemistry, Metabolism 100.0%